Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
But more recently, they have learned to exploit it, both in drugs and as a way to explore biological function
Start low, monitor your response, and combine with diet, exercise, and lifestyle for best results
Inflammation Bowel Dis (2016) 22:113750
US$ 23.72
US$ 28.37
US$ 25.88
US$ 22.31
US$ 26.69
US$ 21.77
US$ 28.95
US$ 25.44
US$ 23.68
US$ 22.13
